Schistosomes: Schistosoma mansoni (Sambon 1907), Schistosoma japonicum (Katsurada 1904), Schistosoma haematobium (Bilharz 1852)

  • Dickson D. Despommier
  • Robert W. Gwadz
  • Peter J. Hotez


Schistosomiasis is an infection caused by three species belonging to the genus Schistosoma: S. mansoni, S. japonicum, and S. haematobium. In addition, S. mekongi has been identified as a pathogen in certain regions of South East Asia and S. intercalatum in West Africa. The World Health Organization estimates that at present 200 million to 300 million people are infected with one or more of these species. The geographic distribution of these parasites reflects that of their specific snail vectors.


Adult Worm Esophageal Varix Schistosoma Mansoni Schistosoma Haematobium Snail Intermediate Host 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Fuller GK, Lemma A, Trinidad H: Schistosomiasis in Omo National Park of southwest Ethiopia. Am J Trop Med Hyg 28: 467–471, 1979Google Scholar
  2. 2.
    World Health Organization: Weekly Epidemiol Rec 64: 171, 1989Google Scholar
  3. 3.
    Warren KS: Helminthic diseases endemic in The United States. Am J Trop Med Hyg 23: 723–730, 1974Google Scholar
  4. 4.
    Manson P: Report of the case of bilharzia from the West Indies. BMJ 2: 1894–1895, 1902PubMedCrossRefGoogle Scholar
  5. 5.
    Sambon LW: New or little known African entozoa. J Trop Med Hyg 10: 117, 1907Google Scholar
  6. 6.
    Piraja de Silva MA: Contribucao para o estudo da schistosomiase na Bahia. Brazil Med 2: 281–283, 1908Google Scholar
  7. 7.
    Leiper RT: Researches on Egyptian Bilharziosis. John Bale Sons and Danielsson, London 1918Google Scholar
  8. 8.
    Katsurada F: The etiology of a parasitic disease. Iji Shimbun 669: 1325–1332, 1904Google Scholar
  9. 9.
    Catto J: Schistosoma cattoi, a new blood fluke of man. BMJ 1: 11–13, 1905PubMedCrossRefGoogle Scholar
  10. 10.
    Majima T: A strong case of liver cirrhosis caused by parasitic ova. Tokyo Ig Za 2: 898–901, 1888Google Scholar
  11. 11.
    Kawanishi K: A report on a study of the “Katayama disease” in Higo-No-Kuni. Tokyo Ig Za 18: 31–48, 1904Google Scholar
  12. 12.
    Fujinami K, Nakamura H: Katayama disease in Hiroshima prefecture: route of infection, development of the worm in the host and animals in Katayama disease in Hiroshima prefecture (Japanese blood sucking worm disease—schistosomiasis japonica). Kyoto Ig Za 6: 224–252, 1909Google Scholar
  13. 13.
    Miyagawa Y: Uber den Wanderungsweg des Schistosomum japonicum von der Haut bis zum Pfortadersystem und uber die Korperkonstitution der jungsten Wurmer zur Zeit der Hautinvasion. Zentralbl Bakteriol Parasit Infekt 66: 406–417, 1912Google Scholar
  14. 14.
    Miyairi K, Suzuki M: Der Zwischenwirt der Schistosoma japonicum Katsurada. Mitt Med Fakultät Kaiserlichen Univ Kyushu 1: 187–197, 1914Google Scholar
  15. 15.
    Griesinger W: Klinische und anatomische Beobachtungen uber die Krankheiten von Aegypten. Arch Physiol Heilk 13: 528–575, 1854Google Scholar
  16. 16.
    Lawrence JD: The ingestion of red blood cells by Schistosoma mansoni. J Parasitol 59: 60–63, 1973PubMedCrossRefGoogle Scholar
  17. 17.
    Chappell CL, Kalter DC, Dresden MH: The hypersensitivity response to the adult worm proteinase, Smw32, in Schistosoma mansoni infected mice. Am J Trop Med Hyg 39: 463–468, 1988PubMedGoogle Scholar
  18. 18.
    Vermund SH, Bradley DJ, Ruiz-Triben E: Survival of Schistosoma mansoni in the human host: estimates from a community-based prospective study in Puerto Rico. Am J Trop Med Hyg 32: 1040–1048, 1983PubMedGoogle Scholar
  19. 19.
    Cohen FE, Gregoret LM, Amiri P, et al: Arresting tissue invasion of a parasite by protease inhibitors chosen with the aid of computer modeling. Biochemistry 30: 11221–11229, 1991PubMedCrossRefGoogle Scholar
  20. 20.
    Marcial-Rojas RA: Schistosomiasis mansoni. In Marcial-Rojas (ed) Pathology of Protozoal and Helminthic Diseases with Clinical Correlation. Williams & Wilkins, Baltimore, 1971, pp 373–413Google Scholar
  21. 21.
    Von Lichtenberg F, Sher A, Gibbons N, et al: Eosinophil-enriched inflammatory response to schistosomula in the skin of mice immune to Schistosoma mansoni. Am J Pathol 84: 479–500, 1976PubMedGoogle Scholar
  22. 22.
    Pearce EJ, Caspar P, Grzych J-M, et al: Down regulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. J Exp Med 173: 159–166, 1991PubMedCrossRefGoogle Scholar
  23. 23.
    Arnon R: Immunoparasitological parameters in schistosomiasis—a perspective view of a vaccine oriented immunochemist. Vaccine 9: 379–394, 1991PubMedCrossRefGoogle Scholar
  24. 24.
    Smithers SR, Terry RJ: The immunology of Schistosomiasis. Adv Parasitol 7: 41–93, 1969PubMedCrossRefGoogle Scholar
  25. 25.
    Butterworth AE, Fulford AJC, Dunne DW, et al: Longitudinal studies on human schistosomiasis. Philos Trans R Soc Lond [Biol] 321: 495–511, 1988CrossRefGoogle Scholar
  26. 26.
    Butterworth AE, Bensted-Smith R, Capron A, et al: Immunity in schistosomiasis mansoni: prevention by blocking antibodies of the expression of immunity in young children. Parasitology 94: 281–300, 1987PubMedCrossRefGoogle Scholar
  27. 27.
    Warren KS: The pathology of schistosome infections. Helminth Abstr Ser A 42: 591–633, 1973Google Scholar
  28. 28.
    Amiri P, Locksley RM, Parslow TG, et al: Tumour necrosis factor alpha restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature 356: 604–607, 1992PubMedCrossRefGoogle Scholar
  29. 29.
    Davis BH, Mahmoud AAF, Warren KS: Granulomatous hypersensitivity to Schistosoma mansoni eggs in thymectomized and bursectomized chickens. J Immunol 113: 1064–1067, 1974PubMedGoogle Scholar
  30. 30.
    Spencer H, Gibson JB: Schistosomiasis. In Spencer H, Dyan AD, Gibson JB (eds) Tropical Pathology. Springer-Verlag, New York, 1973, pp 561–595Google Scholar
  31. 31.
    Scrimgeour EM, Gajdusek CD: Involvement of the central nervous system in Schistosoma mansoni and S. haematobium infection. Brain 108: 1023–1038, 1985PubMedCrossRefGoogle Scholar
  32. 32.
    Andrade ZA, Rocha H: Schistosomal glomerulopathy. Kidney Inter 16: 23–29, 1979CrossRefGoogle Scholar
  33. 33.
    Watt G, Long GW, Caluboquib C, et al: Prevalence of renal involvement in Schistosoma japonicum infection. Trans R Soc Med Hyg 82: 339–342, 1991Google Scholar
  34. 34.
    McGarvey ST, Aligui G, Daniel BL, et al: Child growth and schistosomiasis japonica in northeastern Ley te, Philippines. I. Cross sectional results. Am J Trop Med Hyg 46: 571–581, 1992PubMedGoogle Scholar
  35. 35.
    Stephenson LS, Latham MC, Kurz KM, Kinoti SN: Single dose metrifonate or praziquantel treatment in Kenyan children. II. Effects on growth in relation to Schistosoma haematobium and hookworm egg counts. Am J Trop Med Hyg 41: 445–453, 1989PubMedGoogle Scholar
  36. 36.
    Homeida MA, Tom IE, Nash T, Bennett JL: Association of the therapeutic activity of praziquantel with the reversal of Syminer’s fibrosis induced by Schistosoma mansoni. Am J Trop Med Hyg 45: 360–365, 1991PubMedGoogle Scholar
  37. 37.
    Polderman AM, Gryseek B, Gerold JL, et al: Side effects of praziquantel in the treatment of Schistosoma mansoni in Maniema, Zaire. Trans R Soc Trop Med Hyg 98: 752–754, 1984CrossRefGoogle Scholar
  38. 38.
    Brindley PJ, Sher A: The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response. J Immunol 139: 215–220, 1987PubMedGoogle Scholar
  39. 39.
    Yogore MG Jr, Lewert RM, Blas BL: Seroepidemiology of schistosomiasis japonicum by ELISA in the Philippines. Am J Trop Med Hyg 33: 882–890, 1984PubMedGoogle Scholar
  40. 40.
    King CH, Lombardi G, Lombardi C, et al: Chemotherapy-based control of schistosomiasis haematobia. II. Metrifonate vs. praziquantel in control of infection-associated morbidity. Am J Trop Med Hyg 42: 587–595, 1990PubMedGoogle Scholar
  41. 41.
    Jordan P: Schistosomiasis—research to control. Am J Trop Med Hyg 26: 877–885, 1977PubMedGoogle Scholar
  42. 42.
    Jobin WR, Brown RA, Velez SP, et al: Biological control of Biomphalaria glabrata in major reservoirs of Puerto Rico. Am J Trop Med Hyg 26: 1018–1024, 1977PubMedGoogle Scholar
  43. 43.
    Unrau GO: Individual household water supplies in rural St. Lucia as a control measure against Schistosoma mansoni. Bull WHO 52: 1–8, 1975PubMedGoogle Scholar
  44. 44.
    Butterworth AE: Vaccines against schistosomiasis: where do we stand? Trans R Soc Trop Med Hyg 86: 1–2, 1992PubMedCrossRefGoogle Scholar
  45. 45.
    Capron A, De s saint TP, Capron M, et al: Immunity to schistosomes: progress towards a vaccine. Science 238: 1065–1072, 1987PubMedCrossRefGoogle Scholar
  46. 46.
    Bickle QD, Andrews BJ, Doenhoff MJ, et al: Resistance against Schistosoma mansoni induced by highly irradiated infections: studies on species specificity of immunization and attempts to transfer resistance. Parasitology 90: 301–312, 1985PubMedCrossRefGoogle Scholar
  47. 47.
    Mangold BL, Dean DA: The role of IgG antibodies from irradiated cercaria-immunized rabbits in the passive transfer of immunity to Schistosoma mansoni-infected mice. Am J Trop Med Hyg 47: 821–829, 1992PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1995

Authors and Affiliations

  • Dickson D. Despommier
    • 1
  • Robert W. Gwadz
    • 2
  • Peter J. Hotez
    • 3
  1. 1.College of Physicians and SurgeonsColumbia University, Presbyterian HospitalNew YorkUSA
  2. 2.Laboratory of Malaria Research, National Institute of Allergy and Infectious DiseasesNational Institutes of HealthBethesdaUSA
  3. 3.Yale University School of MedicineNew HavenUSA

Personalised recommendations